☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
bms
PharmaShots Weekly Snapshots (September 02 – September 06, 2024)
September 6, 2024
BMS Reports Results from P-III (MAVA-LTE) Trial of Camzyos to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
September 2, 2024
BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma
July 19, 2024
BMS’ Krazati Receives the US FDA’s Accelerated Approval to Treat Locally Advanced or Metastatic Colorectal Cancer (mCRC)
June 25, 2024
BMS Reports the EMA’s Validation of the Application for Subcutaneous Opdivo
June 21, 2024
BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors
June 14, 2024
Load more...
Back to Home